Arbor Pharms Llc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for ARBOR PHARMS LLC, and when can generic versions of ARBOR PHARMS LLC drugs launch?
ARBOR PHARMS LLC has twelve approved drugs.
There are three US patents protecting ARBOR PHARMS LLC drugs.
There is one patent family member on ARBOR PHARMS LLC drugs in one country and eleven supplementary protection certificates in ten countries.
Summary for Arbor Pharms Llc
International Patents: | 1 |
US Patents: | 3 |
Tradenames: | 12 |
Ingredients: | 7 |
NDAs: | 12 |
Drugs and US Patents for Arbor Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | DEXTROAMPHETAMINE SULFATE | dextroamphetamine sulfate | TABLET;ORAL | 090533-004 | Oct 25, 2011 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Arbor Pharms Llc | ERY-TAB | erythromycin | TABLET, DELAYED RELEASE;ORAL | 062298-003 | Mar 29, 1982 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Arbor Pharms Llc | E.E.S. 400 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 061639-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Arbor Pharms Llc | CETYLEV | acetylcysteine | TABLET, EFFERVESCENT;ORAL | 207916-001 | Jan 29, 2016 | DISCN | Yes | No | 9,427,421 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Arbor Pharms Llc | ERY-TAB | erythromycin | TABLET, DELAYED RELEASE;ORAL | 062298-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Arbor Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Arbor Pharms Llc | SKLICE | ivermectin | LOTION;TOPICAL | 202736-001 | Feb 7, 2012 | 6,103,248 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ARBOR PHARMS LLC drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Lotion | 0.5% | ➤ Subscribe | 2017-09-01 |
International Patents for Arbor Pharms Llc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 2662077 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Arbor Pharms Llc Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1620113 | 300756 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: IVERMECTINE VOOR TOEPASSING IN DE BEHANDELING VAN ROSACEA; NATIONAL REGISTRATION NO/DATE: RVG 115310 20150504; FIRST REGISTRATION: MT MA117/01101 20150402 |
1620113 | 122015000079 | Germany | ⤷ Try a Trial | PRODUCT NAME: IVERMECTIN ZU SEINER VERWENDUNG FUER DIE BEHANDLUNG VON ROSAZEA; NAT. REGISTRATION NO/DATE: 92429.00.00 20150429; FIRST REGISTRATION: MALTA MA 117/01101 20150402 |
1620113 | 15C0069 | France | ⤷ Try a Trial | PRODUCT NAME: IVERMECTINE; NAT. REGISTRATION NO/DATE: NL 44511 20150721; FIRST REGISTRATION: MT - MA 117/01101 20150402 |
1620113 | C300756 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: IVERMECTINE VOOR TOEPASSING IN; NAT. REGISTRATION NO/DATE: RVG 115310 20150504; FIRST REGISTRATION: MA117/01101 20150402 |
1620113 | 92915 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: IVERMECTINE POUR SON USAGE DANS LE TRAITEMENT DE LA ROSACEA; FIRST REGISTRATION: 20150402 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.